What is the evaluation and management of a 1 mm renal stone seen on computed tomography (CT) scan?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Evaluation of 1 mm Renal Stone on CT

A 1 mm renal stone requires active surveillance with follow-up imaging rather than intervention, as stones this small have an extremely high likelihood of spontaneous passage and do not meet size thresholds for surgical treatment.

Initial Management Approach

Conservative management with observation is the appropriate strategy for this stone size. 1 International guidelines (AUA/ES, EAU, and SIU/ICUD) consistently support active surveillance for asymptomatic, non-obstructing caliceal stones, with EAU guidelines specifically stating that active surveillance is acceptable for stones up to 15 mm. 1

Expected Natural History

  • Spontaneous passage is highly likely for stones <4 mm, with 38-71% of symptomatic ureteral calculi in this size range passing without intervention. 2
  • For stones <2 mm specifically, only 4.8% will require intervention during surveillance. 2
  • At 1 mm, this stone falls well below any intervention threshold and has the highest probability of spontaneous passage or remaining asymptomatic.

Follow-Up Imaging Strategy

Annual follow-up imaging is recommended for asymptomatic renal stones under observation. 2, 3

  • Non-contrast CT remains the gold standard for follow-up, with sensitivity of 97% and specificity of 95% for stone detection. 4
  • Low-dose CT protocols (<3 mSv) should be utilized to minimize cumulative radiation exposure while maintaining diagnostic accuracy (pooled sensitivity 97%, specificity 95%). 4
  • Ultrasound can be alternated with CT for annual surveillance to reduce radiation burden, though ultrasound has limited sensitivity (54%) for small stones and tends to overestimate stone size. 5, 2

Indications for Intervention

Surgical treatment would only be indicated if the stone: 1

  • Demonstrates significant growth on follow-up imaging
  • Becomes associated with infection
  • Causes symptomatic obstruction
  • Develops other complications

None of these scenarios are expected with a 1 mm stone, which is far below the 10-20 mm size range where surgical options (fURS, SWL, or PCNL) are typically considered for renal stones. 1

Risk Stratification

This patient has minimal risk of stone-related events. 3

  • Stones >5 mm are associated with higher rates of symptomatic events and need for intervention, but a 1 mm stone falls well below this threshold. 3
  • Stone location matters for larger stones (lower pole stones are less likely to pass), but at 1 mm, location is less clinically relevant. 3

Common Pitfalls to Avoid

  • Do not order contrast-enhanced CT for stone surveillance, as IV contrast may obscure small stones within the collecting system and provides no additional benefit. 4
  • Avoid relying solely on ultrasound for follow-up, as it has poor sensitivity (24-57%) for small stone detection and significantly overestimates stone size in the 0-10 mm range. 1, 5
  • Do not pursue intervention based on stone presence alone without symptoms, growth, or complications, as this represents overtreatment. 1

Practical Follow-Up Schedule

  • First follow-up at 1 year with low-dose non-contrast CT or ultrasound. 2
  • Continue annual imaging for 2-3 years if stone remains stable and asymptomatic. 2
  • Patient education regarding symptoms of stone passage (flank pain, hematuria) should be provided, though intervention is rarely needed for stones this small. 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.